Literature DB >> 16876116

Disulfide bond formation in NGR fiber-modified adenovirus is essential for retargeting to aminopeptidase N.

Dragomira Majhen1, Jelka Gabrilovac, Marc Eloit, Jennifer Richardson, Andreja Ambriović-Ristov.   

Abstract

The peptide motif NGR (asparagine-glycine-arginine) is known to bind to aminopeptidase N (APN). We have constructed five adenoviruses (Ads) bearing NGR in the HI loop of the adenoviral fiber protein. We compared the targeting properties of the NGR peptide within different amino acid environments and showed that their cellular receptor(s) were not identical. Ads containing NGR within potentially cyclic sequences flanked by cysteines retargeted viruses mainly to APN, while Ads containing NGR within linear sequences not containing cysteines retargeted Ads mainly to alpha(v)beta(3) integrin, albeit with a lower affinity. Finally, we show evidence that disulfide bond formation within an Ad bearing the CDCNGRCFC sequence is essential for retargeting to APN, suggesting that this sequence does indeed assume a cyclic structure which facilitates NGR binding to APN. Therefore, our study underscores the importance of cysteine residues flanking targeting peptides for not only affinity but also specificity of the retargeted Ad.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876116     DOI: 10.1016/j.bbrc.2006.07.051

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Disulfide bond formation contributes to herpes simplex virus capsid stability and retention of pentons.

Authors:  Renata Szczepaniak; Jacob Nellissery; Joshua A Jadwin; Alexander M Makhov; Athena Kosinski; James F Conway; Sandra K Weller
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

Review 2.  The neovasculature homing motif NGR: more than meets the eye.

Authors:  Angelo Corti; Flavio Curnis; Wadih Arap; Renata Pasqualini
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

3.  Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.

Authors:  Ayele H Negussie; Jenna L Miller; Goutham Reddy; Steven K Drake; Bradford J Wood; Matthew R Dreher
Journal:  J Control Release       Date:  2010-01-11       Impact factor: 9.776

4.  Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching.

Authors:  Flavio Curnis; Angela Cattaneo; Renato Longhi; Angelina Sacchi; Anna Maria Gasparri; Fabio Pastorino; Paola Di Matteo; Catia Traversari; Angela Bachi; Mirco Ponzoni; Gian-Paolo Rizzardi; Angelo Corti
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

5.  Development of NGR peptide-based agents for tumor imaging.

Authors:  Rongsheng E Wang; Youhong Niu; Haifan Wu; Mohamad Nassir Amin; Jianfeng Cai
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-07-03

6.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

7.  Peptide targeting of adenoviral vectors to augment tumor gene transfer.

Authors:  E N Ballard; V T Trinh; R T Hogg; R D Gerard
Journal:  Cancer Gene Ther       Date:  2012-05-18       Impact factor: 5.987

8.  NGR-peptide-drug conjugates with dual targeting properties.

Authors:  Kata Nóra Enyedi; Szilárd Tóth; Gergely Szakács; Gábor Mező
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

9.  Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain.

Authors:  Ryota Kirikoshi; Noriyoshi Manabe; Ohgi Takahashi
Journal:  Int J Mol Sci       Date:  2017-02-16       Impact factor: 5.923

10.  Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications.

Authors:  Sarah L Hulin-Curtis; James A Davies; Davor Nestić; Emily A Bates; Alexander T Baker; Tabitha G Cunliffe; Dragomira Majhen; John D Chester; Alan L Parker
Journal:  Cancer Gene Ther       Date:  2020-01-06       Impact factor: 5.987

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.